Milestone’s NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

Amicus is focused on delivering significant long-term revenue growth and anticipates surpassing $1 billion in total sales in 2028. The Company anticipates continuing to grow its current commercial ...

In a recent notice, the SEC, whose acting chair was appointed by President Donald Trump, revised its "beneficial ownership ...

Three of the glamping huts will be located along the southwestern perimeter of the proposed lake, while the other three will ...

The decision was made as the looming election is characterised by mass hostility to the official parties and a growing desire among workers and young people for a genuine alternative.

An SCD patient in Bahrain received the gene-editing therapy Casgevy, marking the first time the treatment has been given outside the U.S.

Altuvoct (efanesoctocog alfa) was approved in the U.K. as a treatment for patients with moderate or severe hemophilia A ages ...

An IRS offer in compromise can help you settle tax debt for less than you owe, but it's difficult to qualify for.

Selection and an overweight relative to the benchmark in industrials, ground transportation in particular, detracted from ...

LONDON (Reuters) - The EU's competition chief says U.S. President Donald Trump has upended the "trustful relationship" ...

A UK study found more than 80% of 80 SMA type 1 children on a DMT had scoliosis or other abnormal spinal curvature needing ...